Blog

Washington, D.C. – June 8, 2026 Auxergen presented two high-impact poster presentations that challenge longstanding assumptions in virology and parasitology at the American Society for Microbiology (ASM) Microbe 2026 conference in Washington, D.C. (June 4–7). The posters offer evidence of Multiple Superinfection Events detected in a deadly Marburg Virus outbreak and the discovery of the…

Baltimore, MD – April 6, 2026 — Auxergen Inc. is proud to announce the publication of “Tea Polyphenols in the COVID-19 Era: Mechanistic Insights and Translational Challenges” in the journal Current Issues in Molecular Biology (https://www.mdpi.com/1467-3045/48/4/379). Lead author Harrison Chang, a tenth-grade high school student and intern at Auxergen, provides a critical chemo-biological evaluation of…

Baltimore, MD – December 13, 2025 Auxergen is excited to announce the publication of summer intern Desmond L. Seybold’s first-author paper in International Journal of Molecular Science. Desmond is an undergraduate at the University of Maryland, Baltimore County, and joined us through the IMET Undergraduate Summer Internship Program. Culminating in research conducted over the Summer…

Baltimore, MD – January 22, 2026 Auxergen is proud to announce its latest publication in Virology, led by first author Vincent Tsai. Currently a senior at Wego High School, Vincent Tsai is the first high school student to serve as the lead author of any study published in the journal’s history since founding in 1955….

Baltimore, MD – September 5, 2025 Auxergen, a leading multinational biotechnology company specializing in virology and microbial genomics, announced its participation in the 2025 American Society for Virology (ASV) annual meeting held in Montreal, Canada, from July 14 to 17. The company’s scientific team was selected to deliver three poster presentations, highlighting innovative research in…

Baltimore, Maryland – April 4, 2025 Auxergen announces the establishment of its new, production-capable, state-of-the-art biotech laboratory at the Institute of Marine and Environmental Technology (IMET), marking a significant step almost five years to the day since installing at the Harbor Launch Incubator at IMET on April 11, 2020. The new facilities will enable Auxergen…

Baltimore, Maryland – January 24, 2025 Auxergen has been named one of the top eight “Companies to Watch” in Baltimore for 2025 by the Baltimore Business Journal, a publication reaching over 2.3 million readers annually. This recognition coincides with the fifth anniversary of Auxergen’s incorporation at the Institute of Marine and Environmental Technology (IMET) on…

Baltimore, Maryland – November 5, 2024 Auxergen’s latest research on the rapidly evolving mpox strains has been published in The Lancet Microbe. With a ranking of 2nd out of 132 in the infectious disease category, and 3rd out of 161 in the microbiology category, it is one of the world’s foremost scientific journals. Key Findings:…